City of Hope selects first provost and chief scientific officer

City of Hope named Steven T. Rosen, MD, the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University Feinberg School of Medicine, as its first provost and chief scientific officer.

“I feel privileged to join such a prestigious institution with so many accomplished and talented scientists, clinicians and administrative leaders,” Rosen said. “City of Hope is one of the great treasures in American medicine, with some of the most important discoveries of the last decades coming from its investigators — both in terms of scientific observations, as well as clinical advances.”

An internationally known specialist in hematologic malignancies, Rosen is expected to set the scientific direction of City of Hope as it embarks on a new era of strategic growth, shaping the research and educational vision for the $1.2-billion independent biomedical research, treatment and education institution.

Rosen will work closely with scientists, clinicians and administrative leaders to develop strategies that contribute to City of Hope’s mission to transform basic science into practical benefits for patients suffering from cancer and other life-threatening diseases. He will be responsible for the Comprehensive Cancer Center, the Beckman Research Institute, and the Irell and Manella Graduate School of Biological Sciences.

“City of Hope has established our reputation as an academic medical institution, known for leading-edge research, superior outcomes and compassionate, patient-focused care,” said Robert Stone, president and incoming chief executive officer. “Dr. Rosen’s experience and vision will create the environment necessary to accelerate the pace of meaningful discoveries that extend both quality and length of life.”